Tatsuo Hata
Sendai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Simultaneous and sequential combination of genetic and epigenetic biomarkers for the presence of high-grade dysplasia in patients with pancreatic cyst: Discovery in cyst fluid and test in pancreatic juice.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: December 09, 2022
Prognostic impact of postoperative circulating tumor DNA as a molecular minimal residual disease marker in patients with pancreatic cancer undergoing surgical resection.
Journal: Journal of hepato-biliary-pancreatic sciences
Published: August 05, 2022
Levels of tumor markers CEA/CA 19-9 in serum and peritoneal lavage predict postoperative recurrence in patients with pancreatic cancer.
Journal: Annals of gastroenterological surgery
Published: April 13, 2022
Impact of Tumor-Derived DNA Testing in Peritoneal Lavage of Pancreatic Cancer Patients with and Without Occult Intra-Abdominal Metastases.
Journal: Annals of surgical oncology
Published: July 02, 2021
Acinar Cell Carcinoma with Morphological Change in One Month.
Journal: Internal medicine (Tokyo, Japan)
Published: March 22, 2021
Germline DNA damage repair gene mutations in pancreatic cancer patients with personal/family histories of pancreas/breast/ovarian/prostate cancer in a Japanese population.
Journal: Annals of gastroenterological surgery
Published: March 20, 2021
Circulating tumor DNA as a predictive marker for occult metastases in pancreatic cancer patients with radiographically non-metastatic disease.
Journal: Journal of hepato-biliary-pancreatic sciences
Published: March 06, 2021
A Successful Case of Pancreaticoduodenectomy after Neoadjuvant Therapy for Pancreatic Head Cancer with Acute Pancreatitis Due to Iatrogenic Injury of the Pancreatic Duct
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 20, 2021
Increased neutrophil-lymphocyte ratio predicts recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health Organization classification.
Journal: BMC surgery
Published: December 19, 2020
MicroRNA-593-3p Expression in Peritoneal Lavage Fluid as a Prognostic Marker for Pancreatic Cancer Patients Undergoing Staging Laparoscopy.
Journal: Annals of surgical oncology
Published: August 26, 2020
Duodenal Obstruction Caused by the Long-term Recurrence of Appendiceal Goblet Cell Carcinoid.
Journal: Internal medicine (Tokyo, Japan)
Published: August 08, 2020
Serum Anti-p53 Antibody Can Serve as a Predictive Marker for Histological Grade of Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Journal: Pancreas
Published: June 17, 2020
Last Updated: 09/26/2026